我要投票 好护士Herbapex在鹿胎膏行业中的票数:130
· 外 推 电 报 ·
2025-03-13 04:02:16 星期四

【好护士Herbapex是哪个国家的品牌?】

好护士Herbapex是什么牌子?「好护士Herbapex」是辽宁上药好护士药业(集团)有限公司旗下著名品牌。该品牌发源于辽宁,由创始人左敏在2004-03-19期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力好护士Herbapex品牌出海!通过在本页面挂载好护士Herbapex品牌的产品链接和联系邮箱,可以提高好护士Herbapex产品曝光!跨境电商爆单神器,目前只要100元/年哦~

辽宁好护士药业(集团)有限责任公司坐落于世界文化遗产——五女山山城脚下、辽宁省最大的湖泊——桓龙湖畔,1999年12月公司成立,2004年3月与上海实业集团合资,成为中外合资企业,先后通过GMP、ISO9001、ISO14000等多项认证。

目前集团公司可生产3个剂型,42个品种,其中国家中药保护品种15个,国家基本药物26个,独家生产品种7个,国家医保目录品种19个,基本上形成了以乳癖消为代表的乳系列产品,以尫痹片为代表的痹症系列产品,以强肾片为代表的肾系列产品,以益心宁神片为代表的心脑血管系列产品的产品结构群。主导品种乳癖消片作为问世二十多年的老品种,数十年畅销不衰,并成为治疗妇女乳腺病的首选药物,单品种年销售额超亿元,出口到俄罗斯、哈萨克斯坦、乌克兰、东南亚等地区和国家,在俄罗斯获得“梅奇尼克夫”金奖和“巩固民族健康贡献奖”,为中药在国际市场赢得了荣誉;痹症系列药是治疗风湿病、类风湿病的纯中药制剂,由中华中医药学会风湿病分会焦树德教授经十多年临床研究而开发的独家生产品种,采用辩证施治的原则,对症下药,因其纯中药制剂的特点,对患者无毒副反应,因而广受欢迎。

公司拥有现代化的生产厂房和设备,并采用国内最先进的生产技术,生产管理团队拥有执业药师、工程师等多名专业人才,同时又具有丰富的现场管理经验,生产队伍技术熟练,经验丰富。提取车间年处理药材量5000吨,是国家中药现代化示范工程,总投资3500万,建筑面积4500平方米,该车间采用大孔树脂吸附的先进提取技术,装配全自动化控制系统,实现生产全过程的自动化控制。固体制剂车间总投资2900万,建筑面积4100平方米,年产片剂40亿片,胶囊剂5亿粒,引进高速压片机、高效包衣机、全自动包装线等一系列先进设备,提高生产自动化水平。公司的提取技术和制剂水平在国内同行业处于一流水平。

公司技术研发中心为省级技术研发中心、辽宁省工程技术研究中心、本溪市重点实验室、中国医科大学生物制药研究所研发基地、辽宁中医学院实训基地,配备有国内一流的检测、检验、中试设备和专业的技术研发队伍。该中心在注重新产品开发步入生产、储备、研制的同时,一项重要的任务就是对在产品的生产工艺、设备进行研究,以提高生产技术水平。

公司营销网络覆盖全国(除台湾、西藏),现有营销人员近400人,设有特区办事处3个,大区办事处16个。通过专业推广、学术会议等多种形式提高公司和产品的形象和知名度,公司销售额连年创新高。

09年,公司“苍松”商标被评为全国驰名保护,“好护士”商标被评为辽宁省著名商标,这既是对公司以往业绩和知名度的认可,也是公司再上新台阶的一个新起点。“全国企业文化创新单位”、“辽宁省腾龙企业”、“辽宁省用户满意企业”、“辽宁省高新技术企业”、“中国质量万里行辽宁省示范单位”、“辽宁省农业产业化重点龙头企业”、“辽宁省创驰名保护先锋企业”等荣誉称号和资格认证见证了好护士药业曾经的辉煌业绩。以“做好人,做好药”为价值观的好护士药业,在发展中践行着“托起生命的太阳,呵护人类的健康”的企业宗旨,立志成为维护人类生命健康的“好护士”。

英文翻译:Liaoning good nurse Pharmaceutical (Group) Co., Ltd. is located at the foot of wunushan mountain city, the world cultural heritage, and Huanlong lake, the largest lake in Liaoning Province. The company was founded in December 1999. In March 2004, it became a Sino foreign joint venture with Shanghai industrial group. It has passed GMP, ISO9001, ISO14000 and other certifications. At present, the group company can produce 3 dosage forms, 42 varieties, including 15 national traditional Chinese medicine protection varieties, 26 national essential drugs, 7 exclusive production varieties, 19 national medical insurance catalogue varieties, basically forming a series of dairy products represented by Rupixiao, a series of Bi syndrome products represented by Jabi tablet, a series of kidney products represented by Qiangshen tablet, and a series of yixinningshen tablet The product structure group of cardiovascular and cerebrovascular products. The leading product Rupixiao tablet, as an old one that has been published for more than 20 years, has been selling well for decades, and has become the first choice drug for the treatment of women's breast disease. The annual sales of a single product has exceeded 100 million yuan, and it has been exported to Russia, Kazakhstan, Ukraine, Southeast Asia and other regions and countries. In Russia, it has won the gold medal of "Mechnikov" and the award of "contribution to the consolidation of national health", and it is a Chinese medicine in China The international market has won the honor; arthralgia series medicine is a pure Chinese medicine preparation for treating rheumatism and rheumatoid diseases. Professor Jiao Shude, the rheumatic branch of the Chinese society of traditional Chinese medicine, has developed an exclusive production variety after more than ten years of clinical research. It is based on the principle of dialectical treatment. It is widely welcomed because of the characteristics of its pure Chinese medicine preparation and its non-toxic side effects on patients. The company has modern production plant and equipment, and adopts the most advanced production technology in China. The production management team has many professional talents such as licensed pharmacists and engineers, as well as rich on-site management experience. The production team is skilled and experienced. The annual processing capacity of the extraction workshop is 5000 tons, which is a national modernization demonstration project of traditional Chinese medicine, with a total investment of 35 million yuan and a building area of 4500 square meters. The workshop adopts the advanced extraction technology of macroporous resin adsorption, assembles the full automatic control system, and realizes the automatic control of the whole production process. The total investment of the solid preparation workshop is 29 million, with a construction area of 4100 square meters. The annual output of the workshop is 4 billion tablets and 500 million capsules. A series of advanced equipment such as high-speed tablet pressing machine, high-efficiency coating machine and automatic packaging line are introduced to improve the production automation level. The company's extraction technology and preparation level are in the first-class level in the same industry in China. The company's technology R & D center is a provincial technology R & D center, Liaoning Engineering Technology Research Center, Benxi Key Laboratory, research and development base of Institute of Biopharmaceutics, China Medical University, and practical training base of Liaoning College of traditional Chinese medicine, equipped with domestic first-class testing, testing, pilot equipment and professional technology R & D team. While the center is focusing on the development of new products into production, storage and development, an important task is to study the production process and equipment of products in process, so as to improve the production technology level. The company's marketing network covers the whole country (except Taiwan and Tibet), with nearly 400 marketing personnel, 3 special zone offices and 16 regional offices. Through professional promotion, academic conferences and other forms to improve the image and popularity of the company and its products, the company's sales volume has reached a new high year after year. In 2009, the company's "Cangsong" trademark was awarded the national well-known protection, "good nurse" trademark was awarded the famous trademark of Liaoning Province, which is not only the recognition of the company's past performance and popularity, but also a new starting point for the company to go to a new level. "National enterprise culture innovation unit", "Liaoning Tenglong enterprise", "Liaoning user satisfaction Enterprise", "Liaoning high tech enterprise", "Liaoning demonstration unit of China's quality wanlihang", "key leading enterprise of agricultural industrialization in Liaoning Province", "Liaoning well-known protection pioneer enterprise" and other honorary titles and qualification certification have witnessed the past Brilliant achievements. The good nurse pharmaceutical industry, with the value of "be a good person, do a good job in medicine", practices the enterprise tenet of "holding up the sun of life, caring for human health" in the development, and is determined to become a "good nurse" to maintain human life and health.

本文链接: https://www.waitui.com/brand/bd64c2ad9.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

平安好医生:2024年营收48.1亿元,首次全年盈利

36氪获悉,平安好医生发布2024年年度业绩公告。报告期内,公司录得营收48.1亿元,调整后净利润1.58亿元。其中,综合金融客户端(F端)及企业端(B端)业务收入同比增长17.2%。F端业务收入超24亿元,同比增长9.6%。B端业务收入同比提升32.7%,录得收入超14亿。截至报告期末,累计服务的企业客户数达2049家,较去年同期增长35.9%。

3分钟前

热门中概股美股盘前多数下跌,小鹏汽车跌超6%

36氪获悉,热门中概股美股盘前多数下跌,截至发稿,小鹏汽车跌超6%,极氪跌超4%,哔哩哔哩跌超3%,百度、微博、蔚来、理想汽车跌超1%;小马智行涨超2%,知乎涨超1%。

3分钟前

蓝思科技:拟发行H股股票并在香港联交所上市

36氪获悉,蓝思科技发布公告,公司拟发行境外上市外资股(H股)股票,并申请在香港联合交易所有限公司(简称“香港联交所”)主板挂牌上市。公司将充分考虑现有股东利益及境内外资本市场情况,在股东大会决议有效期内(即经公司股东大会审议通过之日起24个月或同意延长的其他期限)择机完成本次发行上市。

3分钟前

鸿博股份:子公司英博数科与百川智能解除云服务协议

36氪获悉,鸿博股份发布公告,2023年12月4日,公司全资子公司英博数科与百川智能签署了《云服务协议》,英博数科向百川智能提供一定规模的智算服务器所有的算力和资源以及配套软件、应用,以及技术服务,合同期限为三年,自2024年1月30日至2027年1月31日,合同约定开始履行日期为2024年1月30日。自合同签订起,英博数科与百川智能始终致力于推进原合同的实施,并与百川智能建立了良好的合作关系,但受不可抗力因素影响,原合同已无法继续履行,公司与百川智能于近日签署《确认函》,经双方协商一致,停止原合同相关合作,且双方不存在争议,互不承担责任。由于原合同尚未产生收入,合同解除预计不会对公司财务及经营状况造成重大不利影响。

3分钟前

交易员提高对美联储降息的押注,预计年内至少降息两次

交易员提高对美联储降息的押注,预计年内至少降息两次。(财联社)

3分钟前

本页详细列出关于东鳌的品牌信息,含品牌所属公司介绍,东鳌所处行业的品牌地位及优势。
咨询